Resmed (RMD) Operating Leases (2019 - 2026)

Resmed's Operating Leases history runs 8 years deep, the most recent figure standing at $149.8 million for Q1 2026.

• Quarterly Operating Leases rose 8.59% year-over-year to $149.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $149.8 million (up 8.59% YoY) and the FY2025 annual result came in at $153.0 million, up 8.18% from the prior year.
• Operating Leases was $149.8 million for Q1 2026 at Resmed, down from $154.1 million in the prior quarter.
• Across five years, Operating Leases topped out at $154.1 million in Q4 2025 and bottomed at $112.4 million in Q3 2023.
• A 5-year average of $133.4 million and a median of $138.0 million in 2025 frame the typical range for Operating Leases.
• Annual changes were most pronounced in 2022 — Operating Leases dropped 12.43% — and 2024, when it increased 28.49%.
• Resmed's Operating Leases stood at $116.4 million in 2022, then gained by 20.79% to $140.6 million in 2023, then dropped by 1.06% to $139.2 million in 2024, then increased by 10.76% to $154.1 million in 2025, then decreased by 2.79% to $149.8 million in 2026.
• Business Quant data shows RMD's Operating Leases at $149.8 million in Q1 2026, $154.1 million in Q4 2025, and $147.8 million in Q3 2025.